A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer.
Hoffmann-La Roche
Hoffmann-La Roche
National Cancer Institute (NCI)
National Cancer Institute (NCI)
The University of Hong Kong
Sanofi